News

Alvotech: Potential Victim Of Pharma Tariff Threats (Rating Downgrade)
Alvotech faces challenges with potential tariffs and profitability, despite strong revenue growth and a robust pipeline. See ...
Regulus Therapeutics Acquisition By Novartis Due To Key Farabursen Advancements
Regulus Therapeutics will be acquired by Novartis AG for $7 per share in cash. Click here for more information on RGLS ...
Investor's Business Daily on MSN22m
BridgeBio's Pfizer-Rivaling Heart Drug Just Obliterated Sales Expectations
BridgeBio's new heart drug — a rival to Pfizer's blockbuster Vyndaqel — smashed sales expectations in its first full quarter ...
Target ALS Launches "Behind Every Breakthrough" Campaign for ALS Awareness Month to Spotlight Progress and People Driving ALS Research Forward
In recognition of ALS Awareness Month this May, Target ALS is proud to launch Behind Every Breakthrough—a month-long multimedia campaign that highlights the global momentum in ALS research and the ...
The Manila Times32m
Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining
SAN ANTONIO, April 30, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (OTC: SCPX) ("Scorpius” or "the Company”), an ...
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump's pharma tariffs loom
Here's a list of the companies that have announced new U.S. investments since Trump took office: Merck on Tuesday said it is ...
Films For Action59m
Israel’s War on Palestinian Children: 17,000 Killed, No Schools Left in Gaza
Ruweida Amer, a journalist and teacher from Gaza, joins the show to report on Israel's US-backed genocide of Palestinians amid relentless bombardment and the total blockade of the ...